Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ICML 2019 | CLL trial highlights from 15-ICML

Ahmad Alhuraiji • 20 Jun 2019
ICML 2019
Chronic Lymphocytic Leukemia Leukemia Ibrutinib Obinutuzumab Venetoclax
CLL12 CLL14

Ahmad Alhuraiji, MD, of the Kuwait Cancer Control Center, Kuwait City, Kuwait, discusses three major chronic lymphocytic leukemia (CLL) trials that were presented at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland. These include a Swiss trial, CLL14 (NCT02242942), and CLL12 (NCT02863718).

More from Ahmad Alhuraiji

1:33
Work at the Kuwait Cancer Control Center
Ahmad Alhuraiji • 20 Jun 2019

Related Videos

8:40
Investigating PP2A-based therapeutic strategies for KMT2A-rearranged acute leukemia
Maria Teresa Esposito • 25 Apr 2024
1:55
Factors to consider when choosing a treatment option for patients with CLL
Piers Patten • 28 Apr 2024
1:17
The curative potential of alloSCT in the treatment of HR-MDS
Jurjen Versluis • 22 Apr 2024
10:34
Remission induction therapy prior to alloSCT in AML: insights from the ASAP trial
Johannes Schetelig • 19 Apr 2024
The content of VJHemOnc is intended for healthcare professionals